Targeted Alpha Therapy as a Multiscale Design Problem: From Radioactive Decay to Therapeutic Outcome. [PDF]
Lazić I +4 more
europepmc +1 more source
<sup>177</sup>Lu-trastuzumab radionuclide therapy: a promising strategy for trastuzumab-resistant brain metastases in HER2+ breast cancer. [PDF]
Santos L +9 more
europepmc +1 more source
Novel Radiotherapy Delivery Modalities and Their Potential to Synergize with Immunotherapy. [PDF]
Mihaylov IB, Spieler B.
europepmc +1 more source
Radionuclide‑drug conjugates in lung cancer: advances in precision therapy and clinical translation. [PDF]
Liu J +5 more
europepmc +1 more source
GATE Monte Carlo evaluation of cellular dosimetry for <sup>119</sup>Sb in targeted radionuclide therapy. [PDF]
Hasnaki A +4 more
europepmc +1 more source
<sup>177</sup>Lu-Labeled Ectonucleotide Pyrophosphatase/Phosphodiesterase 3 Monoclonal Antibody-Targeted Therapy for Clear Cell Renal Cell Carcinoma. [PDF]
Luo H +8 more
europepmc +1 more source
Comparative Dosimetry of Single and Hybrid <sup>177</sup>Lu, <sup>161</sup>Tb, and <sup>90</sup>Y in PSMA-Targeted Therapy. [PDF]
Oni OM, Smith TAD.
europepmc +1 more source
Development of a Highly Effective Bifunctional Ligand 2E-C-NETA for Targeted Lu-177 Therapy: Synthesis, Radiolabeling, In Vitro Stability, and In Vivo Biodistribution. [PDF]
Chen Y +8 more
europepmc +1 more source
Special Issue "Targeted Therapy of Cancer: Innovative Drugs and Molecular Tools". [PDF]
Giansanti F, Ippoliti R.
europepmc +1 more source

